Decreased levels of NIS expression and/or diminished targeting of NIS to the plasma membrane (PM) of thyroid cancer cells represent the principal mechanisms of radioiodide-refractory disease (9–11). Here, SLC5A5 is linked to thyroid gland carcinoma.